Quantcast

Latest Human papillomavirus Stories

2014-06-23 04:20:45

Inovio's Immunotherapy will Treat Women with Inoperable HPV-caused Cancer BLUE BELL, Pa., June 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity, clinical responses and disease-free survival of its DNA immunotherapy product, INO-3112, in treating human papillomavirus (HPV)-associated cervical cancer. INO-3112 is a combination of Inovio's lead active immunotherapy...

2014-06-17 23:02:39

New research report “Human Papillomavirus Infections Vaccine Pipeline Analysis” drawn up by PNS Pharma is available at MarketPublishers.com. London, UK (PRWEB) June 17, 2014 Human papillomaviruses represent a group of over 150 viruses which are related to each other, with certain types of viruses being able to cause warts (papillomas). There exist only two human papillomavirus vaccines which are currently marketed worldwide. Both these vaccines are prepared with the use of the...

2014-06-11 08:30:52

Inovio Responds to False and Misleading Speculation Regarding Immunotherapy Study BLUE BELL, Pa., June 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) wishes to clarify that a third party article published on June 10, 2014, was misrepresentative of facts and can only be taken as malicious. The referenced article does not reflect the progress, status, and potential of Inovio's active immune therapy technology and products and is rife with false and misleading...

2014-06-10 16:26:58

LAVAL, QC, June 10, 2014 /CNW Telbec/ - Roche announced that Health Canada approved the cobas® 4800 HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. Roche has also launched the fully automated CINtec® PLUS test to improve the detection and early intervention of pre-cancerous cervical disease. The Health Canada approved CINtec® PLUS cytology test helps identify women with high-grade pre-cancerous cervical...

2014-06-10 12:30:44

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014http://www.reportbuyer.com/pharma_healthcare/treatments/human_papillomavirus_hpv_associated_cancer_pipeline_review_h1_2013.html Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Direct's, 'Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014', provides an...

2014-06-10 04:22:14

Inovio Targets Most Rapidly Increasing Cancer in Men BLUE BELL, Pa., June 10, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity and clinical responses of its immunotherapy product, INO-3112, in treating human papillomavirus (HPV)- associated head and neck cancer. INO-3112 is a combination of Inovio's lead active immunotherapy product, VGX-3100, and its proprietary immune...

2014-06-01 23:02:52

A new survey found that “More than two-thirds of healthy Americans are teeming with HPV,” according to a report by NBC News published on May 20, 2014 (1). polyDNA reviews the report, and recommends Gene-Eden-VIR and Novirin to help the immune system target the latent human papillomavirus (HPV). Rochester, NY (PRWEB) June 01, 2014 A majority of Americans are infected with one or more strains of the human papillomavirus (HPV) (1). Dr. Yingfei Ma said that “The HPV 'community'...

2014-05-27 23:10:19

“Only 24% of (Hispanic male) participants believed that the HPV vaccine could prevent future problems, and 53% said they would not be vaccinate,” according to the Journal of Transcultural Nursing from May 19, 2014 (1). polyDNA reviews the study and recommends Gene-Eden-VIR and Novirin to help the immune systems target the latent human papillomavirus. Rochester, NY (PRWEB) May 27, 2014 A new study reported the attitudes of Hispanic men regarding HPV vaccination. Researchers learned...

2014-05-24 23:02:48

Teenage girls who practice risky sex have higher rates of HPV and herpes than those in the general population according to a study reported on Healio.com on May 20, 2014 (1). polyDNA reviews the study and recommends that individuals talk to their doctors about the natural antivirals Gene-Eden-VIR and Novirin. Rochester, NY (PRWEB) May 24, 2014 At-Risk teenage girls are more likely to develop an infection with HPV or herpes. The study “evaluated 861 female adolescents aged 12 to 19 years...

2014-05-23 23:10:30

“Executives at Gaitherburg-based Novavax (NVAX) say the company has laid the groundwork for a vaccine to combat Middle East Respiratory Syndrome (MERS),” according to The Washington Post website from May 11, 2014 (1). polyDNA congratulates the Novavax team, and recommends Gene-Eden-VIR and Novirin, the natural antivirals. Rochester, NY (PRWEB) May 23, 2014 polyDNA, the maker of Gene-Eden VIR and Novirin, congratulates Novavax (NVAX) for laying “the groundwork for a vaccine to combat...


Latest Human papillomavirus Reference Libraries

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

More Articles (1 articles) »
Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related